285 related articles for article (PubMed ID: 16107734)
21. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.
Fan P; Siwak DR; Abderrahman B; Agboke FA; Yerrum S; Jordan VC
Mol Cancer Ther; 2019 Oct; 18(10):1684-1695. PubMed ID: 31511352
[TBL] [Abstract][Full Text] [Related]
23. Estradiol enhances CIP2A expression by the activation of p70 S6 kinase.
Choi YA; Koo JS; Park JS; Park MY; Jeong AL; Oh KS; Yang Y
Endocr Relat Cancer; 2014 Apr; 21(2):189-202. PubMed ID: 24280132
[TBL] [Abstract][Full Text] [Related]
24. Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells.
Deb TB; Coticchia CM; Dickson RB
J Biol Chem; 2004 Sep; 279(37):38903-11. PubMed ID: 15247222
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
26. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells.
Fan P; Agboke FA; McDaniel RE; Sweeney EE; Zou X; Creswell K; Jordan VC
Eur J Cancer; 2014 Jan; 50(2):457-68. PubMed ID: 24183378
[TBL] [Abstract][Full Text] [Related]
29. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
30. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
Liu J; Li J; Sidell N
Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
[TBL] [Abstract][Full Text] [Related]
31. c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.
Mukherjee S; Conrad SE
J Biol Chem; 2005 May; 280(18):17617-25. PubMed ID: 15757889
[TBL] [Abstract][Full Text] [Related]
32. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.
Wang Y; Zhou D; Phung S; Masri S; Smith D; Chen S
Mol Endocrinol; 2011 Jan; 25(1):72-82. PubMed ID: 21084382
[TBL] [Abstract][Full Text] [Related]
33. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
34. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
[TBL] [Abstract][Full Text] [Related]
35. SRC Increases
Abdullah C; Korkaya H; Iizuka S; Courtneidge SA
Mol Cell Biol; 2018 Mar; 38(6):. PubMed ID: 29263157
[TBL] [Abstract][Full Text] [Related]
36. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
[TBL] [Abstract][Full Text] [Related]
38. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
Kyprianou N; English HF; Davidson NE; Isaacs JT
Cancer Res; 1991 Jan; 51(1):162-6. PubMed ID: 1899037
[TBL] [Abstract][Full Text] [Related]
39. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.
Martin JL; Baxter RC
Endocrinology; 2007 May; 148(5):2532-41. PubMed ID: 17289850
[TBL] [Abstract][Full Text] [Related]
40. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
Chewchuk S; Guo B; Parissenti AM
PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
